Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...

- ZEVASKYN is the only FDA-approved therapy to treat RDEB wounds with a single application - ...

4FRONT-1 Phase 3 expected data readout accelerated from H2 2027 to H1 2027 4FRONT-2 Phase 3 trial initiated ahead of schedule Streamlined late-stage clinical and pre-commercial organization aligns ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

I strongly object to the Friday letter to the editor by Mike Growney, who conflates objective journalism as provided by The Associated Press with opinions from a conservative columnist. Mr ...

Vector Security, Inc. announced its achievement of UL Alarm Validation Scoring (AVS-01) standard certification, a significant milestone that further solidifies its commitment to improving alarm ...

The report offers an in-depth analysis of vectorized antibodies via in vivo expression of DNA/RNA. It explores stakeholders, R&D pipelines, drug compositions, and business deals as of June 2025, ...

OpenAI should continue to be controlled by a nonprofit because the artificial intelligence technology it is developing is ...

FRISCO, Texas (AP) — Big 12 Commissioner Brett Yormark is doubling down on his preference for staying with only five automatic qualifiers if the College Football Playoff does expand to ...

MINNEAPOLIS (AP) — Minnesota coach P.J. Fleck has agreed to a one-year contract extension through the 2030 season. The university's board of regents approved the deal. His $6 million annual ...

ATLANTA (AP) — Georgia Tech has named Ryan Alpert as its vice president and director of athletics. The school announced his hiring on Tuesday. Alpert previously served as senior deputy ...

UNDATED (AP) — A new college sports agency has rejected certain NIL deals involving donor-backed collectives. These collectives, formed to funnel money to athletes or schools, fail to meet NCAA ...